FDA reverses course, will review Moderna’s mRNA flu vaccine candidate - The Hill

FDA reverses course, will review Moderna’s mRNA flu vaccine candidate  The Hill

EU regulator backs approval for Moderna's combined COVID and flu vaccine - Reuters

EU regulator backs approval for Moderna's combined COVID and flu vaccine  Reuters

Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline - MarketWatch

Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline  MarketWatch

Bayer files separate lawsuits against Moderna, J&J and Pfizer-BioNTech over COVID vaccine tech - ...

Bayer files separate lawsuits against Moderna, J&J and Pfizer-BioNTech over COVID vaccine tech  Fierce Pharma

After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vacc...

After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3  Fierce Biotech

FDA authorizes updated COVID vaccines with restrictions on who can get them - CBS News

FDA authorizes updated COVID vaccines with restrictions on who can get them  CBS News

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV - Reuters

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV  Reuters

HHS cancels funding for Moderna to develop vaccines to combat bird flu - The Washington Post

HHS cancels funding for Moderna to develop vaccines to combat bird flu  The Washington Post

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation - CNN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation  CNN

Moderna’s COVID-19 vaccine to roll out across the US - C&EN

Moderna’s COVID-19 vaccine to roll out across the US  C&EN

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report - The New England Journal of Medicine

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report  The New England Journal of Medicine

Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine - BioSpace

Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine  BioSpace

Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection | npj Vaccines - Na...

Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection | npj Vaccines  Nature

Explanatory Video about the COVID-19 Vaccine Released on YouTube - 慶應義塾

Explanatory Video about the COVID-19 Vaccine Released on YouTube  慶應義塾

Japan moves to bolster vaccine R&D after COVID-19 exposed startling weakness - Science | AAAS

Japan moves to bolster vaccine R&D after COVID-19 exposed startling weakness  Science | AAAS

Moderna or Pfizer: Which vaccine is a better booster? Experts weigh in - CBC

Moderna or Pfizer: Which vaccine is a better booster? Experts weigh in  CBC

More Than 12.7 Billion Shots Given: Covid-19 Vaccine Tracker - Bloomberg.com

More Than 12.7 Billion Shots Given: Covid-19 Vaccine Tracker  Bloomberg.com

Many provinces withdraw COVID-19 shots, leaving gap as new ones await approval - The Globe and Mail

Many provinces withdraw COVID-19 shots, leaving gap as new ones await approval  The Globe and Mail

Moderna says COVID-19 vaccine is 94.5% effective in preliminary analysis - C&EN

Moderna says COVID-19 vaccine is 94.5% effective in preliminary analysis  C&EN

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine  The New England Journal of Medicine

Court orders Swiss government to disclose Covid vaccine contracts - SWI swissinfo.ch

Court orders Swiss government to disclose Covid vaccine contracts  SWI swissinfo.ch

UK cements 10-year-partnership with Moderna in major boost for vaccines and research - GOV.UK

UK cements 10-year-partnership with Moderna in major boost for vaccines and research  GOV.UK

Why Switzerland’s Moderna Covid-19 vaccine deal is risky - SWI swissinfo.ch

Why Switzerland’s Moderna Covid-19 vaccine deal is risky  SWI swissinfo.ch

Lonza ‘scaling up’ Moderna’s promising Covid-19 vaccine process - SWI swissinfo.ch

Lonza ‘scaling up’ Moderna’s promising Covid-19 vaccine process  SWI swissinfo.ch

Swiss factory rushes to prepare for Moderna Covid-19 vaccine - SWI swissinfo.ch

Swiss factory rushes to prepare for Moderna Covid-19 vaccine  SWI swissinfo.ch